What the ChondroFiller evidence actually showsChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
ChondroFiller duration vs hyaluronic acid and ArthrosamidChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.
ChondroFiller injection cost and UK accessChondroFiller injection costs £2,100–£8,000 in the UK, is delivered as a single ultrasound-guided outpatient procedure, and is not commissioned by the NHS.ChondroFiller injection costs £2,100–£8,000 in the UK, is delivered as a single ultrasound-guided outpatient procedure, and is not commissioned by the NHS.
Questions to ask before a ChondroFiller injectionChondroFiller is an injectable collagen scaffold that prompts the body's cells to rebuild cartilage as it degrades—unlike hyaluronic acid, which lubricates, or permanent fillers, which cushion. Delivered as an outpatient ultrasound-guided procedure, published data show 30-point IKDC improvement at 12 months, though long-term durability beyond two years remains unestablished.ChondroFiller is an injectable collagen scaffold that prompts the body's cells to rebuild cartilage as it degrades—unlike hyaluronic acid, which lubricates, or permanent fillers, which cushion. Delivered as an outpatient ultrasound-guided procedure, published data show 30-point IKDC improvement at 12 months, though long-term durability beyond two years remains unestablished.
ChondroFiller Injection for Shoulder Cartilage DefectsChondroFiller is an ultrasound-guided collagen scaffold that recruits the patient's own progenitor cells to repair focal shoulder cartilage defects; early observational data reports marked pain reduction and functional improvement from the outpatient procedure.ChondroFiller is an ultrasound-guided collagen scaffold that recruits the patient's own progenitor cells to repair focal shoulder cartilage defects; early observational data reports marked pain reduction and functional improvement from the outpatient procedure.
ChondroFiller injection for hip cartilage defectsChondroFiller is an injectable collagen scaffold placed into the hip via ultrasound guidance that recruits the patient's own progenitor cells to differentiate into repair cartilage; the procedure is completed in an outpatient clinic without surgical debridement or general anaesthesia.ChondroFiller is an injectable collagen scaffold placed into the hip via ultrasound guidance that recruits the patient's own progenitor cells to differentiate into repair cartilage; the procedure is completed in an outpatient clinic without surgical debridement or general anaesthesia.
ChondroFiller injection recovery timelineChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.ChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.
ChondroFiller injection for ankle osteochondral lesionsChondroFiller is an injectable collagen scaffold that repairs ankle cartilage by recruiting the patient's own cells to rebuild the lesion, rather than introducing foreign cells or merely masking symptoms.ChondroFiller is an injectable collagen scaffold that repairs ankle cartilage by recruiting the patient's own cells to rebuild the lesion, rather than introducing foreign cells or merely masking symptoms.
ChondroFiller safety across 19,000 real-world treatmentsAcross 19,000 real-world treatments, ChondroFiller records no serious adverse device effects and a reoperation rate of 3–8%, compared to 41% for microfracture and 37% for ACI/MACI.Across 19,000 real-world treatments, ChondroFiller records no serious adverse device effects and a reoperation rate of 3–8%, compared to 41% for microfracture and 37% for ACI/MACI.
ChondroFiller injection after tibial plateau fractureCartilage damage from tibial plateau fractures does not repair itself, leading to progressive joint wear. ChondroFiller, a collagen scaffold injected under ultrasound, recruits the patient's own cells to generate hyaline-like repair tissue; three-year data show functional improvement of 32.4 points, exceeding the threshold for meaningful clinical benefit.Cartilage damage from tibial plateau fractures does not repair itself, leading to progressive joint wear. ChondroFiller, a collagen scaffold injected under ultrasound, recruits the patient's own cells to generate hyaline-like repair tissue; three-year data show functional improvement of 32.4 points, exceeding the threshold for meaningful clinical benefit.
ChondroFiller injection cost and what affects itChondroFiller injection costs £3,000–£8,000 depending on cartilage defect size: one box £3,000, two boxes £5,500, three boxes £8,000, each including consultation, ultrasound guidance, implant, injection and six-week follow-up.ChondroFiller injection costs £3,000–£8,000 depending on cartilage defect size: one box £3,000, two boxes £5,500, three boxes £8,000, each including consultation, ultrasound guidance, implant, injection and six-week follow-up.
Who qualifies for ChondroFiller injectionChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.ChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.